Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
small cell lung cancer nivolumab nejm | 0.16 | 0.1 | 2384 | 69 |
small cell lung cancer nivolumab | 1.28 | 0.3 | 9375 | 89 |
non small cell lung cancer trials nivolumab | 1.79 | 0.1 | 1125 | 26 |
small cell lung cancer nivolumab trial | 0.23 | 0.5 | 6683 | 17 |
nejm small cell lung cancer | 1.96 | 0.4 | 9226 | 42 |
small cell lung cancer nivolumab results | 0.54 | 0.8 | 887 | 92 |
small cell lung cancer nivolumab fda | 1.82 | 0.2 | 6083 | 99 |
small cell lung cancer nivolumab ipilimumab | 0.21 | 0.1 | 2313 | 88 |
small cell lung cancer nivolumab chemotherapy | 1.72 | 0.5 | 4732 | 32 |
small cell lung cancer nivolumab fda approval | 1.95 | 0.7 | 5932 | 83 |
small cell lung cancer nivolumab treatment | 0.1 | 0.2 | 3074 | 48 |
small cell lung cancer nivolumab survival | 0.48 | 0.6 | 2139 | 65 |
small cell lung cancer nivolumab cost | 0.75 | 0.8 | 7555 | 29 |
pembrolizumab non small cell lung cancer nejm | 1.6 | 0.9 | 9541 | 87 |
small cell lung cancer nivolumab dose | 0.8 | 0.2 | 2977 | 62 |
nivolumab in lung cancer | 0.41 | 0.4 | 9256 | 44 |
nivolumab neoadjuvant lung cancer | 0.42 | 0.2 | 298 | 36 |
nivolumab for renal cell carcinoma nejm | 0.16 | 0.6 | 8874 | 54 |
nivolumab ipilimumab lung cancer | 0.72 | 0.8 | 4879 | 69 |